Analyst Research

Report Title Price
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : ValuEngine, Inc.
Provider : Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Catalyst Pharmaceutical Partners Inc Closes Previously Announced $15.1 Million Registered Direct Offering

Tuesday, 10 Sep 2013 11:52am EDT 

Catalyst Pharmaceutical Partners Inc announced that it has closed its previously announced offering of 8.8 million shares of its common stock in a registered direct public offering. The offering price was $1.72 per share, resulting in gross proceeds of approximately $15.1 million. Roth Capital Partners acted as the exclusive placement agent for the offering and Aegis Capital Corp., Maxim Group LLC and H.C. Wainwright & Co. acted as financial advisers with respect to the offering. 

Company Quote

-0.02 -0.55%
28 Aug 2015